Related Experiment Videos
Lipoprotein profiles and glucose tolerance in lean and obese chimpanzees
B G Steinetz1, C Randolph, D Cohn
1Laboratory for Experimental Medicine and Surgery in Primates (LEMSIP), NYU Medical Center, Tuxedo 10987, USA.
Journal of Medical Primatology
|January 1, 1996
Summary
Obese and lean chimpanzees on a low-fat diet showed metabolic abnormalities. These animals can serve as models for human metabolic diseases.
Area of Science:
- Primate metabolic research
- Comparative pathology
- Biomedical research using animal models
Background:
- Obesity and metabolic disorders are significant human health concerns.
- Dietary fat content is a known factor in metabolic health.
- Chimpanzees may offer insights into human metabolic disease mechanisms.
Purpose of the Study:
- To compare serum lipid profiles and glucose tolerance in obese versus lean chimpanzees.
- To investigate metabolic abnormalities in chimpanzees on a controlled, low-fat diet.
- To assess the potential of chimpanzees as models for human metabolic diseases.
Main Methods:
- Serum lipid profiles (including low-density lipoprotein cholesterol) were analyzed.
- Glucose tolerance tests were performed.
- Obese and lean chimpanzees were maintained on a 10.9% fat diet.
Main Results:
- Hypercholesterolemia was observed in both obese (7/14) and lean (6/17) chimpanzees.
- Abnormal total cholesterol/high-density lipoprotein cholesterol ratios were found in both groups (3 obese, 3 lean).
- Abnormal glucose tolerance was present in two obese and one lean chimpanzee.
Conclusions:
- Chimpanzees can exhibit metabolic abnormalities, including hypercholesterolemia and impaired glucose tolerance, even on low-fat diets.
- Captive chimpanzees represent valuable surrogates for studying human metabolic diseases.
- These findings highlight the complexity of metabolic regulation beyond dietary fat intake.